DIAGONAL BIO AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0278 SEK | +1.09% |
|
-10.03% | -92.12% |
| 31/05 | Diagonal Bio AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 23/05 | Diagonal Bio AB Appoints Fata Mrsic as Chief Financial Officer, Effective June 14, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 1.05M | - | - | - | - | - | |
| 45.51B | - | |||||
| 38.52B | ||||||
| 38.13B | ||||||
| 30.74B | - | |||||
| 26.03B |
- Stock Market
- Equities
- DIABIO Stock
- Charts Diagonal Bio AB
- Sector Chart
